GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Prostatype Genomics PROGEN.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.10

+1.93%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Prostatype Genomics annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 594,000SEK 199,000SEK 1.4mSEK 683,000SEK 10,000
Operating income−SEK 39.1m−SEK 40.9m−SEK 39.2m−SEK 28.7m−SEK 15.5m
Net income−SEK 44.5m−SEK 41.1m−SEK 41.4m−SEK 29.1m−SEK 15.6m
Free cash flow−SEK 24.1m−SEK 52.6m−SEK 37.7m−SEK 27.7m−SEK 18.6m
Total assetsSEK 50.9mSEK 42.0mSEK 49.2mSEK 30.9mSEK 40.2m
Shareholders' equitySEK 26.5mSEK 33.5mSEK 24.7mSEK 26.2mSEK 35.9m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.